COVID-19 and cardiovascular diseases: viewpoint for older patients

被引：1
作者：
Boureau, Anne-Sophie [1 ,2 ]
De Decker, Laure [1 ]
Berrut, Gilles [1 ]
Hanon, Olivier [3 ]
机构：
[1] CHU Nantes, Pole Gerontol Clin, Nantes, France
[2] Univ Nantes, CHU Nantes, CNRS, Inserm,Inst Thorax, Nantes, France
[3] Univ Paris 05, Serv Geriatrie, Hop Broca, Hop Univ Paris Ctr,EA 4468, Paris, France
来源：
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DU VIEILLISSEMENT | 2020年 / 18卷 / 02期
关键词：
COVID-19; myocardial injury; cardiovascular diseases; older patients; RENIN-ANGIOTENSIN SYSTEM; CLINICAL CHARACTERISTICS; INHIBITORS; PREVALENCE;
D O I：
10.1684/pnv.2020.0864
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. The link between cardiovascular disease and COVID-19 appears to be twofold. First, some reports of data indicate that certain groups of patients are more at risk of COVID-19. This includes patients with cardiovascular risk factors or pre-existing cardiovascular conditions and older patients. In addition, these patients incur disproportionately worse outcome. Second, SARS-CoV2 infection can be complicated by life-threatening cardiovascular acute diseases. Despite the rapid evolution of data on this pandemic, this review aims to highlight the cardiovascular considerations related to COVID-19 whether as comorbidities including concerns and uncertainty regarding the effect of renin-angiotensin-aldosterone system (RAAS) inhibitors on angiotensin conversion enzyme 2 or related to acute cardiovascular complications.
引用
收藏
页码：141 / 149
页数：9
相关论文
共 50 条
[1]   Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State [J].
Arentz, Matt ;
Yim, Eric ;
Klaff, Lindy ;
Lokhandwala, Sharukh ;
Riedo, Francis X. ;
Chong, Maria ;
Lee, Melissa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1612-1614
[2]   Drugs and the renin-angiotensin system in covid-19 [J].
Aronson, Jeffrey K. ;
Ferner, Robin E. .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
[3]  
BOUCHON JP, 1984, REV PRATICIEN, V34, P888
[4]   Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020 [J].
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (15) :465-471
[5]   Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study (vol 368, m1091, 2020) [J].
Chen .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
[6]   Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19 [J].
Cheng, Hao ;
Wang, Yan ;
Wang, Gui-Qiang .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :726-730
[7]   COVID-19 and Cardiovascular Disease [J].
Clerkin, Kevin J. ;
Fried, Justin A. ;
Raikhelkar, Jayant ;
Sayer, Gabriel ;
Griffin, Jan M. ;
Masoumi, Amirali ;
Jain, Sneha S. ;
Burkhoff, Daniel ;
Kumaraiah, Deepa ;
Rabbani, LeRoy ;
Schwartz, Allan ;
Uriel, Nir .
CIRCULATION, 2020, 141 (20) :1648-1655
[8]  
Danzi GB, 2020, EUR HEART J, DOI [10.1093/eurheartj/ehaa254/5813284, DOI 10.1093/EURHEARTJ/EHAA254/5813284]
[9]   Influenza vaccination as secondary prevention for cardiovascular disease: A science advisory from the American Heart Association/American College of Cardiology [J].
Davis, Matthew M. ;
Taubert, Kathryn ;
Benin, Andrea L. ;
Brown, David W. ;
Mensah, George A. ;
Baddour, Larry M. ;
Dunbar, Sandra ;
Krumholz, Harlan M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (07) :1498-1502
[10]   Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic [J].
Driggin, Elissa ;
Madhavan, Mahesh V. ;
Bikdeli, Behnood ;
Chuich, Taylor ;
Laracy, Justin ;
Biondi-Zoccai, Giuseppe ;
Brown, Tyler S. ;
Nigoghossian, Caroline Der ;
Zidar, David A. ;
Haythe, Jennifer ;
Brodie, Daniel ;
Beckman, Joshua A. ;
Kirtane, Ajay J. ;
Stone, Gregg W. ;
Krumholz, Harlan M. ;
Parikh, Sahil A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) :2352-2371
12345